(Q45901707)

17 December 2017

title

High-throughput biochemical kinase selectivity assays: panel development and screening applications. (English)

1 reference

17 December 2017

author name string

Amy Card

1

1 reference

17 December 2017

Chris Caldwell

2

1 reference

17 December 2017

Hyunsuk Min

3

1 reference

17 December 2017

Bina Lokchander

4

1 reference

17 December 2017

Hualin Xi

5

1 reference

17 December 2017

Simone Sciabola

6

1 reference

17 December 2017

Ajith V Kamath

7

1 reference

17 December 2017

Susan L Clugston

8

1 reference

17 December 2017

William R Tschantz

9

1 reference

17 December 2017

Leyu Wang

10

1 reference

17 December 2017

Deborah J Moshinsky

11

1 reference

17 December 2017

publication date

10 December 2008

1 reference

17 December 2017

Journal of Biomolecular Screening

published in

1 reference

17 December 2017

volume

14

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

31-42

1 reference

17 December 2017

The protein kinase complement of the human genome

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1087057108326663

Review: side effects of approved molecular targeted therapies in solid cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108326663

Erlotinib in previously treated non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108326663

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108326663

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108326663

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108326663

Kinase inhibition with BAY 43-9006 in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108326663

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108326663

Chemical genomic and proteomic methods for determining kinase inhibitor selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108326663

A small molecule-kinase interaction map for clinical kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108326663

A quantitative analysis of kinase inhibitor selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108326663

A spectrophotometric assay for quantitative determination of kcat of herpes simplex virus type 1 thymidine kinase substrates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108326663

The selectivity of protein kinase inhibitors: a further update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108326663

Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108326663

Comparison of on-chip and off-chip microfluidic kinase assay formats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108326663

Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108326663

Development of a Transcreener kinase assay for protein kinase A and demonstration of concordance of data with a filter-binding assay format

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108326663

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108326663

Chemogenomics: structuring the drug discovery process to gene families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108326663

Computational approaches to model ligand selectivity in drug design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108326663

Predicting kinase selectivity profiles using Free-Wilson QSAR analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108326663

21 January 2018

Identifiers

DOI

10.1177/1087057108326663

1 reference

17 December 2017

1 reference

17 December 2017